Krukar, Katarzyna Maria, et al. “Clinical Use of Abemaciclib a Cyclin-Dependent Kinase (CDK) 4 6 Inhibitor in Patients With Breast Cancer — Literature Review”. Journal of Education, Health and Sport, vol. 68, Sept. 2024, p. 55282, doi:10.12775/JEHS.2024.68.55282.